Travera uses a breakthrough technology to measure which cancer drugs work against each individual’s unique cancer cells.
Travera's investors include National Science Foundation, MedTech Innovator.
Travera is headquartered in Cambridge, United States.
Travera uses a breakthrough technology to measure which cancer drugs work against each individual’s unique cancer cells.
Travera is at the Non-equity Assistance stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Travera — Funding & Investors." VCBacked, June 6, 2023, https://www.vcbacked.co/company/travera. Accessed September 29, 2026.
VCBacked. (2023). Travera — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/travera
{{cite web |title=Travera — Funding & Investors |url=https://www.vcbacked.co/company/travera |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated